Who are Ambrosiabiosciences's investors?

Ambrosiabiosciences's investors include Colorado BioScience Association, Biotechnology Value Fund, Boulder Ventures.

How much funding has Ambrosiabiosciences raised?

Ambrosiabiosciences has disclosed $16M raised across 1 of its 2 known rounds.

Where is Ambrosiabiosciences headquartered?

Ambrosiabiosciences is headquartered in Boulder, US.

Ambrosiabiosciences

Boulder, US · Founded 2024 · 39 employees on LinkedIn · 3 known investors

Find your way into Ambrosiabiosciences

Ambrosia Biosciences is a drug discovery company developing orally delivered, small molecule therapies for obesity and other metabolic disorders. It operates U.S.-based biology and chemistry laboratories along with an NMR facility and structural biology and computational chemistry capabilities to advance programs from hit to IND.

Biotech Healthtech Longevity

Founders & leadership

Nicholas TraggisExecutive

Board

Kyle Lefkoff Chairman of the Board and FounderGeneral Partner at Boulder Ventures

David SnitmanBoard director

William S. MarshallBoard director

John OrwinBoard director

Investors · 3

Colorado BioScience Associationlisted by Colorado BioScience Association

How we know: Colorado BioScience Association's portfolio page · Not right? Tell us

Biotechnology Value FundreportedSan Francisco

How we know: funding news · press coverage · Not right? Tell us

Boulder VenturesreportedBoulder · $1M – $4M

How we know: board seat on SEC Form D · funding news · boulderventures.com · the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

$16M disclosed across 1 of 2 rounds · 2024–2026

Undisclosed amountSeries BMar 2026
Source ↗

▶$16MraisedAug 2024 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

David SnitmanDirector
William S. MarshallDirector
Nicholas TraggisExecutive Officer, Director
Kyle LefkoffDirector
John OrwinDirector

Offering amount: $25M
Amount sold: $16M
First sale: Jul 2024
Incorporated: Corporation, Delaware, 2024
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Ambrosiabiosciences do?: Ambrosia Biosciences is a drug discovery company developing orally delivered, small molecule therapies for obesity and other metabolic disorders. It operates U.S.-based biology and chemistry laboratories along with an NMR facility and structural biology and computational chemistry capabilities to advance programs from hit to IND.
Who are Ambrosiabiosciences's investors?: Ambrosiabiosciences's investors include Colorado BioScience Association, Biotechnology Value Fund, Boulder Ventures.
How much funding has Ambrosiabiosciences raised?: Ambrosiabiosciences has disclosed $16M raised across 1 of its 2 known rounds.
Where is Ambrosiabiosciences headquartered?: Ambrosiabiosciences is headquartered in Boulder, US.